Waki, Kayoko
Yokomizo, Kanako
Kawano, Kouichiro
Tsuda, Naotake
Komatsu, Nobukazu
Yamada, Akira http://orcid.org/0000-0003-3157-9070
Article History
Received: 9 January 2020
Accepted: 28 April 2020
First Online: 11 May 2020
Compliance with ethical standards
:
: Akira Yamada is a board member of the Bright Path Biotherapeutics (Kawasaki, Japan). The other authors have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The clinical studies had been approved by the Kurume University Ethics Committee and registered with the UMIN Clinical Trial Registry under trial numbers UMIN3083 and UMIN1482.
: Informed consent was obtained from all individual participants included in the study.